ASX Announcement – Licensing deal for Korea
6 September 2016
Licensing deal for Korea
Medical Developments International Limited (“MDI”) (ASX: MVP) is delighted to announce it has reached agreement with BL&H Co Ltd (“BL&H”) for the exclusive distribution rights of Penthrox® in Korea.
The transaction includes upfront and milestone payments of AUD $1.2 million and BL&H will manage the registration, reimbursement and approval process of Penthrox in Korea. BL&H expect to obtain approval and launch Penthrox in Korea during FY18.
For details relating to the full ASX release, please click on the following link ASX Announcement: Licensing deal for Korea